Alnylam Pharmaceuticals, Inc. <ALNY.O>: Wells Fargo cuts target price to $256 from $316
ALNY•Related News
Atmus Filtration Technologies Increases Quarterly Dividend
ATMU•
BTQ Technologies schedules shareholder webinar on Q2 results, corporate update
BTQ•
Engine Capital Urges H.B. Fuller’s Board Of Directors To Run A Market Check For The Building Adhesive Solutions Segment And The Entire Company
FUL•
Target Corp <TGT.N>: Truist Securities raises target price to $147 from $130
TGT•
Old Republic declares quarterly dividend of $0.315 a share
ORI•